Steven Mondia, M.S., joined Statistics Collaborative, Inc. (SCI) in 2014. He is a member of the American Statistical Association, the Bay Area SAS Users Group, and the Golden Key International Honour Society.
At SCI, Mr. Mondia has worked with trials evaluating treatments for type 2 diabetes, Alport disease, Niemann-Pick Type C1 disease, C. difficile infection, kidney disease, adolescent obesity, respiratory syncytial virus infection, heart failure, epilepsy, acute myeloid leukemia, advanced breast cancer, and metastatic melanoma. In his role as a biostatistician on these studies he performs statistical analyses, generates analysis datasets, graphs, tables, and listings, validates program code, develops table shells and assists in the writing of study reports, statistical analysis plans, and meeting minutes. Mr. Mondia has served as the project manager and lead statistical programmer for trials evaluating treatments for glioblastoma and non-small cell lung cancer. In this role, he manages teams of programming and research staff and communicates with clients and DMC members.
He received his B.S. in Biology from the State University of New York at Stony Brook (2006) and his M.S. in Biostatistics from California State University at East Bay (2013).
To contact SCI about a potential project, please call us at 202.247.9700 or click below.
Statistics Collaborative is experencing a business interruption due to circumstances beyond our control. Please call our main company phone number for details and updates.